MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of the novel Biopump™ technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., the Company’s President and CEO, will present a corporate overview at the 11th Annual Israeli Life Sciences Industry Biomed 2011 Conference taking place at the David Intercontinental Hotel in Tel Aviv, Israel from May 21-23, 2012. Dr. Pearlman will deliver the Company’s presentation on Monday, May 21 at 4:30 p.m. (local time) in Hall C.
